Fortrea Holdings (FTRE) Interest & Investment Income (2023 - 2026)

Fortrea Holdings (FTRE) reported Interest & Investment Income of -$19.1 million for Q1 2026, up 14.35% on a YoY basis from -$16.7 million in Q1 2025, and up 17.67% quarter-over-quarter from -$23.2 million in Q4 2025.

Fortrea Holdings (FTRE) Interest & Investment Income (2023 - 2026) Analysis & Trends

Fortrea Holdings has reported Interest & Investment Income for 4 years, with the latest figure at -$19.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Interest & Investment Income rose 14.35% year-over-year to -$19.1 million; the trailing twelve-month figure through Mar 2026 stood at -$88.2 million (up 21.11% YoY), and the FY2025 full-year result was -$91.4 million, up 26.17% from the prior year.
  • Interest & Investment Income for Q1 2026 stood at -$19.1 million, up from -$23.2 million in the prior quarter.
  • The five-year high for Interest & Investment Income was -$700000.0 in Q2 2023, with the low at -$45.2 million in Q2 2024.
  • Historically, Interest & Investment Income has averaged -$25.3 million across 4 years, with a median of -$22.9 million in 2025.
  • Annual changes were most pronounced in 2024 — Interest & Investment Income sank 6357.14% — and 2025, when it soared 48.45%.
  • Fortrea Holdings' Interest & Investment Income stood at -$34.5 million in 2023, then jumped by 36.52% to -$21.9 million in 2024, then declined by 5.94% to -$23.2 million in 2025, then increased by 17.67% to -$19.1 million in 2026.
  • The last three Interest & Investment Income figures came in at -$19.1 million (Q1 2026), -$23.2 million (Q4 2025), and -$22.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 597,319.59
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 40.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 305,000.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 103,341.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 114.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - -14.79 Mn
10 Fortrea Holdings 1.43 Bn 1.28 Bn 123.60 Mn -19.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -19.10 Mn
Dec 31, 2025 -23.20 Mn
Sep 30, 2025 -22.60 Mn
Jun 30, 2025 -23.30 Mn
Mar 31, 2025 -22.30 Mn
Dec 31, 2024 -21.90 Mn
Sep 30, 2024 -22.40 Mn
Jun 30, 2024 -45.20 Mn
Mar 31, 2024 -34.30 Mn
Dec 31, 2023 -34.50 Mn
Sep 30, 2023 -34.60 Mn
Jun 30, 2023 -700,000.00